Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
High dose antigen treatment with a peptide epitope of myelin basic protein modulates T cells in multiple sclerosis patients.
Intractable vomiting as an initial presentation of lupus-related neuromyelitis optica.
IL7Rα Contributes to Experimental Autoimmune Encephalomyelitis through Altered T Cell Responses and Nonhematopoietic Cell Lineages.
The many faces of impaired bladder emptying.
Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
Multiple sclerosis: 7 T MRI reveals cortical lesions associated with disability in MS.
Myelinated mouse nerves studied by X-ray phase contrast zoom tomography.
Is β-catenin neutralization cross-involved in the mechanisms mediated by natalizumab action?
Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever.
A modality-agnostic patch-based technique for lesion filling in multiple sclerosis.
[Oral treatments in multiple sclerosis].
Reassessment of Lhermitte's sign in multiple sclerosis.
Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome.
A decade from discovery to therapy: Lingo-1, the dark horse in neurological and psychiatric disorders.
Prevalence of Incidental Narrowing of the Superior Segment of the Internal Jugular Vein in Patients Without Multiple Sclerosis.
Brain Tissue Volumes and Perfusion Change with the Number of Optic Neuritis Attacks in Relapsing Neuromyelitis Optica: A Voxel-Based Correlation Study.
Recessively transmitted predominantly motor neuropathies.
Depressive syndromes in neurological disorders.
Pseudobulbar affect: prevalence and management.
The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells.
DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.
Employment and multiple sclerosis: Policy, programming, and research recommendations.
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis.
Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury.
Pages
« first
‹ previous
…
573
574
575
576
577
578
579
580
581
…
next ›
last »